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Introduction
Psoriasis is a chronic immune-mediated and inflammatory skin disease. It is considered a systemic rather than a simply cutaneous disease, sustained by a low-level inflammatory status, which promotes the development of several comorbidities which share the same pathogenic background throughout time [1] . It is now considered as one of the most common immune-mediated disorders, with an imbalance between T helper type 1 (Th1)/Th17 and Th2 cytokine expression [2] . Following T cell activation and the recruitment of other cells of the immune system, keratinocytes are stimulated to proliferate, produce mediators responsible of further migration of immune cells and promote angiogenesis. In addition, the inflammatory process is maintained via a positive feedback loop due to the immune cell and cytokine production by keratinocytes [3] [4] [5] [6] [7] . In this scenario, it has been already demonstrated that mesenchymal stem cells (MSCs) are involved early in psoriasis onset and progression. MSCs isolated from skin of psoriatic patients show an imbalance between Th1/Th17 and Th2 pathways, reflecting the phenotype of differentiated skin cells [4, 8] . Even more, an altered microenvironment in psoriatic lesions may induce resident MSCs to produce angiogenic and proinflammatory mediators sustaining skin lesion development [9] . This study aimed to evaluate the influence of MSCs isolated from healthy people (H-MSCs) on MSCs from psoriatic patients (PsO-MSCs). H-MSCs and PsO-MSCs were isolated and characterized. Then, a co-culture was performed, and both proliferation of PsO-MSCs and expression of cytokines linked to Th1/Th17 and Th2 pathways were assayed before and after co-culture.
Materials and methods
In this study, approved by Politechnic Marche University Ethical Commitee (Protocol 2016 0360 OR) and conducted in accordance with the Declaration of Helsinsky, we enrolled 11 Caucasian patients (five males, six females, mean age 47 6 8Á5), after written consent was obtained.
They were suffering from chronic, stable, plaque-type psoriasis with body surface area (BSA) >10%, psoriasis area severity index (PASI) > 10 and dermatology life quality index (DLQI) > 10. None of the patients reported symptoms or signs related to psoriatic arthritis.
They were unresponsive to previous conventional treatments, including topical applications of corticosteroids, retinoids, vitamin D 3 derivates and systemic administration of cyclosporin, methotrexate, psoralen plus ultraviolet A (UVA) phototherapy (PUVA), UVA and narrow-band ultraviolet B (UVB-Nb), and they were free from systemic or topical therapies for almost 3 and 1 months, respectively. As acitretin has a long tissue accumulation time, patients who had received acitretin within the last 2 years were excluded from the study.
For MSC isolation, all psoriatic patients received a skin punch biopsy, taken from the left arm, in the middle area of extensor surface, performed with a 5-mm sterile cutaneous skin punch biopsy device (Gima Medical Devices s.r.l., Rome, Italy) after local anaesthesia with lidocaine 2%.
H-MSCs were isolated from 11 skin samples obtained from plastic surgery procedures in healthy subjects.
Isolation, culture and characterization of MSCs
Samples from healthy and psoriatic people were treated as reported previously [10] [11] [12] and cultured with mesenchymal stem cell growth medium (MSCGM; Lonza, Basel, Switzerland). A phase-contrast microscopy (Leica DM IL; Leica Microsystems GmbH, Wetzlar, Germany) was used to observe the growth and the morphology of cells. Making use of an algorithm available online (http://www.doublingtime.com), the doubling time (DT) was calculated as DT 5 t 3 lg2/(lgNt 2lgN0), where N 0 and N t are the number of inoculated or harvested cells, respectively, and t is the time of culture in hours. Then, cells were characterized as established in the minimal criteria by Dominici for the definition of human MSCs [13] . The plastic-adherence in standard culture conditions, the specific immunophenotype and the differentiation potential towards osteogenic, chondrogenic and adipogenic lineages were assessed. For all the analyses, cells at third and fifth passages and confluence of approximately 80% were used. RT-PCR and enzyme-linked immunosorbent assay (ELISA) array after co-cultures with healthy MSCs. H-MSCs cultured individually were used for comparative purposes.
Total RNA was isolated from 1 3 10 6 cells at the fourth passage using 5 Prime PerfectPure RNA Purification (5 Prime, Hamburg, Germany) and retrotranscribed in cDNA (GoScript TM Reverse Transcription System; Promega, Milan, Italy). All samples were tested in triplicate with the housekeeping genes ribosomal protein lateral stalk subunit P0 (RPLP0) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) for data normalization. Of the two, GAPDH was the most stable and was used for subsequent normalization. After amplification, melting curves were acquired. Direct detection of PCR products was monitored by measuring the fluorescence produced by SYBR Green I dye (EVA Green PCR Master Mix; Bio-Rad, Hercules, CA, USA) binding to double-strand DNA after every cycle. These measurements were then plotted against cycle numbers. The parameter threshold cycle (Ct) was defined as the cycle number at which the first detectable increase above the threshold in fluorescence was observed. Table 1 . Secretion of the same factors was detected on conditioned medium using the Multi-Analyte ELISA array Kit (Qiagen, Hilden, Germany). Briefly, medium conditioned by each sample of PsO-MSCs (before and after co-culture) and H-MSCs was used for the test. Samples were dispensed into a 96-well microtitre plate and incubated for 2 h at room temperature. After washing, avidin-horseradish peroxidase (HRP)-conjugated antibody was added to the plate and incubated for 30 min. Finally, captured cytokines were detected by addition of substrate solution. Reaction was assessed at 450 nm with a microtitre plate reader (Multiskan Go microplate reader; Thermo Scientific, Monza, Italy) within 30 min of stopping the reaction. Absorbances of cytokines in the conditioned media were determined and concentrations were expressed in pg/ml. Data are mean 6 s.d. from three independent experiments.
Statistical analysis
All data were analysed using GraphPad Prism software (version 6.0; La Jolla, CA, USA). All reported data were continuous variables expressed as means 6 s.d. The normal distribution of continuous variables was verified with the Kolmogorov-Smirnov test. Statistical analyses included the ordinary one-way analysis of variance (ANOVA) test for multiple comparison, and a P-value less than 0Á05 was considered to be statistically significant.
Results
H-MSCs and PsO-MSCs showed similar behaviour related to characterization, with no statistically relevant differences. In addition, co-culture experiments made with different donors evidenced no significant dissimilarities. Therefore, results are reported as mean 6 s.d. for healthy, psoriatic or co-cultured cells in each analysis.
Characterization of MSCs
After approximately 7 days, cells with a typical fibroblastlike morphology started to be visible near the biopsy pieces, both from psoriatic and healthy subjects (Fig. 1a) . Proliferation rate was monitored from the first to the twelfth passages by calculating the DT, as reported above. PsO-MSCs showed a lower DT than H-MSCs, at approximately 19 6 2 for H-MSCs and 11 6 2 for PsO-MSCs for the first eight passages. Then, in both cases, DT increased gradually up to passage 12 to 39 6 2 h for H-MSCs and 36 6 1 h for PsOMSCs (Fig. 1b) . Cells were then characterized following the minimal criteria of Dominici [13] . First, cells were plasticadherent in culture. Secondly, cells showed a typical mesenchymal stem cell profile, resulting positive to CD73, CD90 and CD105 and negative for the other considered antigens (HLA-DR, CD14, CD19, CD34, CD45) ( Table 2) . Cells were also able to differentiate between osteogenic (Fig. 2a,b ,e,f), adipogenic (Fig. 2c,g ) and chondrogenic (Fig. 2d,h ) lineages, as demonstrated by the specific stainings. Differentiation potential among various samples of H-MSCs or PsO-MSCs and between samples of HMSCs and PsO-MSCs showed no dissimilarity. Minimal criteria were therefore satisfied, and cells defined as MSCs.
Influence of H-MSCs on PsO-MSC proliferation
After 72 h, the proliferation of H-MSCs, PsO-MSCs and H-MSCs/PsO-MSCs was assessed by XTT test. Co-cultured PsO-MSCs showed a reduction on cell proliferation of approximately 30-35% compared to mock (Fig. 3 ), approaching the value of H-MSCs.
Expression profile of cytokines belonging to Th1/ Th17 and Th2 pathways
Expression of selected cytokines belonging to the Th1/Th17 and Th2 pathways was evaluated by RT-PCR and ELISA before and after co-cultures. Before co-cultures, mRNA analysis revealed that PsO-MSCs express significantly higher 
Positive immunolabelling (1) was defined as a level of fluorescence > 90% of the corresponding isotype-matched control antibodies. Percentages < 2% were considered negative (-). No differences were noted among the 12 samples (11 healthy subjects and 11 psoriatic patients). (Fig. 4a) . These data were confirmed completely by the ELISA test, which showed that IL-4, IL-5 and IL-10 were secreted equally by PsO-MSCs and H-MSCs, while IL-6, IL-12, IL-13, IL-17A, TGF-b, IFN-g, TNF-a and G-CSF were secreted more by PSO-MSCs than H-MSCs. Finally, the level of secreted IL-2 was lower in PsO-MSCs than in H-MSCs (Fig.4b) . After co-culture, secretion of IL-6, IL-12, IL-13, IL-17A, TNF-a, TG-Fb, IFN-g and G-CSF decreased, reaching levels similar to those obtained from H-MSCs (Fig. 4b) . Conversely, the secretion of IL-2 was increased compared to individually cultured PsO-MSCs and closer to H-MSCs (Fig.  4b) . Because when analysing the conditioned medium of cocultures it is impossible to differentiate whether the variations observed in the levels of secreted cytokines are related to H-or PsO-MSCs, the analysis of mRNA was repeated in co-cultured PsO-MSCs. As shown in Fig. 4a , the levels of mRNAs detected in PsO-MSCs after co-culture with H-MSCs retrace the changes observed in cytokine secretion.
Discussion
Mesenchymal stem cells (MSCs) are stromal-derived nonhaematopoietic progenitor cells residing in several adult and neonatal tissues as bone marrow, umbilical cord, adipose tissue, amniotic fluid, placenta, dental pulp and skin [15] . MSCs have been revealed to possess distinct immunemodulatory properties, which induce immune tolerance in different inflammatory conditions [16] . They exert these effects by influencing on proliferation, recruitment, function and fate of both innate and adaptive immune cells, including T cells [17] , B cells [18] , dendritic cells (DCs) [19] and natural killer (NK) cells [20] . All these properties are probably mediated through direct cell-to-cell contact and paracrine fashion by secreting several immune-modulatory mediators.
The anti-inflammatory and immune-modulatory activity of MSCs may be paramount in the restoration of localized or systemic conditions for normal healing and tissue regeneration [21] .
Based on accumulated results, MSCs obtained from patients with psoriasis have been shown to be impaired in their anti-inflammatory function against Th cell subsets [4, 22] . Liu et al. [22] have demonstrated recently that psoriatic MSCs have a reduced immunosuppressive capability, as they found a decreased ability to inhibit cell proliferation in psoriatic MSCs co-cultured with activated T cells in vitro, even after stimulation with IFN-g together with TNF-a. These results are in line with evidence that MSC phenotype and activity can be regulated by intrinsic mechanisms and extrinsic cues that emanate from the microenvironment, one of which is inflammation. However, MSCs can react differently to inflammation, and the interplay between inflammation and MSCs activity is a growing research field.
In psoriasis, the Th1/Th17 inflammatory milieu has been demonstrated to influence directly both the phenotype and proliferative rate of MSCs, driving them to produce several Th1/Th17 cytokines [IL-6, IL-12, IL-13, TNF-a, G-CSF, vascular endothelial growth factor (VEGF) and inducible nitric oxide synthase (iNOS)]. In this scenario, MSCs act as a source of inflammatory molecules, able to perpetrate the inflammation actively during the course of disease.
The aim of this study was to evaluate whether and how the interaction between healthy MSCs (H-MSCs) and psoriatic MSCs (PsO-MSCs) in a co-culture in-vitro model could modify the proliferative activity and phenotype profile of psoriatic MSCs.
Before co-culture, the proliferation rate of PsO-MSCs was significantly higher than H-MSCs; the increased growth rate reflects the increased proliferation of keratinocytes followed by the changes in the epidermis that resembles unsuppressed wound healing.
The level of secreted cytokines at baseline confirm the imbalance of Th1/17 versus the Th2 axis also observed in our previous studies [4, 8, 23] : MSCs from psoriatic patients secrete higher amounts of Th1/Th17 inflammatory molecules (IL-6, IL-12, IL-13, IL-17A, TGF-b, IFN-g, TNF-a and G-CSF) than MSCs from control subjects. Conversely, IL-2 is less secreted by PsO-MSCs than H-MSCs. After co-culture of H-MSCs with PsO-MSCs, healthy MSCs seem to exert a 'positive' influence on PsO-MSCs, driving the inflammatory phenotypical profile of PsOMSCs towards a physiological pattern. All the changes observed on PsO-MSCs result from a paracrine mechanism exerted on them by healthy MSCs, as the two MSCs populations were not in direct contact but separated by a porous membrane. Note that, unlike pharmaceutical treatments that deliver a single agent at a specific dose, MSCs are site -regulated and secrete bioactive factors and signals at variable concentrations in response to local microenvironmental cues [21] .
First, the proliferation rate decreases towards values nearer to those observed in H-MSCs and keratinocyte hyperproliferation is consequently reduced. Our results underline that co-cultures restore conditions closer to the physiological microenvironment; at baseline, the levels of secreted IL-6, IL-12, IL-13, IL-17A, TGF-b, IFN-g, TNF-a and G-CSF are significantly higher in PsO-MSCs than in H-MSCs. Secretion of the same cytokines is significantly lower in co-cultured PsO-MSCs than in individually cultured cells, reaching levels not significantly different from those of H-MSCs. The modulation of secretion of IL-2, a cytokine belonging to the Th2 pathway, is the opposite: lower in PsO-MSCs than in H-MSCs at baseline, and shows an increase after co-cultures.
In our previous study, we evaluated the secretion of selected cytokines in PsO-MSCs before and after 12 weeks' treatment with TNF-a inhibitors. TNF-a is a proinflammatory cytokine that amplifies inflammation through several distinct pathways [24] [25] [26] : facilitating entry of inflammatory cells into lesional skin, through induction of adhesion molecules on vascular endothelial cells; stimulating the production of other proinflammatory mediators; and finally activating dermal macrophages and dendritic cells; inhibiting Th1/Th17 T cells. The three TNF-a antagonists actually available for the treatment of psoriasis (infliximab, etanercept, and adalimumab) [27] , even if with some differences, act by blocking and inactivating the molecule.
We have already demonstrated that the in-vivo administration of TNF-a inhibitors produced a decrease in IL-6, IL-12, IL-17A, TNF-a and G-CSF, as well as an increase of IL-2 secretion in PsO-MSCs; similar results have been obtained by the cross-talk between H-MSCs and PsOMSCs in the co-culture system. The paracrine effect exerted by healthy MSCs on psoriatic MSCs in vitro seems able to mimic the effect biological drug administration in vivo.
Limitations
Eleven psoriatic patients and 11 healthy subjects were enrolled into this study; even if the results from each participant of the same subgroup were very similar, the sample size should be enlarged. Moreover, all the observations derive from in-vitro experiments and should be considered as preliminary results, and need to be confirmed by further studies focusing upon the interaction between H-MSCs, inflammatory microenvironment and differentiated cells in vivo. 
Healthy MSCs restore psoriatic MSCs

Perspectives
This study provides a molecular-based response to the ever-increasing evidence of the therapeutic efficacy of allogenic MSCs infusion in psoriatic patients, as reported recently in the literature [28] , stimulating research into the field of stem cells for the treatment of psoriasis.
